300 related articles for article (PubMed ID: 28852804)
21. Peroxisome proliferator-activated receptor-δ activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in type 2 diabetes.
Lee EY; Kim GT; Hyun M; Kim S; Seok S; Choi R; Lee MY; Chung CH
Nephrol Dial Transplant; 2012 Nov; 27(11):4069-79. PubMed ID: 22892126
[TBL] [Abstract][Full Text] [Related]
22. Autophagy protects human podocytes from high glucose-induced injury by preventing insulin resistance.
Xin W; Li Z; Xu Y; Yu Y; Zhou Q; Chen L; Wan Q
Metabolism; 2016 Sep; 65(9):1307-15. PubMed ID: 27506738
[TBL] [Abstract][Full Text] [Related]
23. Aberrant activation of Notch-1 signaling inhibits podocyte restoration after islet transplantation in a rat model of diabetic nephropathy.
He Y; Zhang M; Wu Y; Jiang H; Fu H; Cai Y; Xu Z; Liu C; Chen B; Yang T
Cell Death Dis; 2018 Sep; 9(10):950. PubMed ID: 30237561
[TBL] [Abstract][Full Text] [Related]
24. The PKGIα/VASP pathway is involved in insulin- and high glucose-dependent regulation of albumin permeability in cultured rat podocytes.
Rachubik P; Szrejder M; Audzeyenka I; Rogacka D; Rychłowski M; Angielski S; Piwkowska A
J Biochem; 2020 Dec; 168(6):575-588. PubMed ID: 32484874
[TBL] [Abstract][Full Text] [Related]
25. Suppressed ER-associated degradation by intraglomerular cross talk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease.
Fujimoto D; Kuwabara T; Hata Y; Umemoto S; Kanki T; Nishiguchi Y; Mizumoto T; Hayata M; Kakizoe Y; Izumi Y; Takahashi S; Mukoyama M
FASEB J; 2020 Nov; 34(11):15577-15590. PubMed ID: 32996639
[TBL] [Abstract][Full Text] [Related]
26. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
27. An In Vitro Method to Analyze Glucose Uptake in Podocytes.
Lay AC; Coward RJ
Methods Mol Biol; 2020; 2067():139-143. PubMed ID: 31701450
[TBL] [Abstract][Full Text] [Related]
28. Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway.
Kim DY; Kang MK; Lee EJ; Kim YH; Oh H; Kang YH
Mol Nutr Food Res; 2018 Oct; 62(19):e1800302. PubMed ID: 29987888
[TBL] [Abstract][Full Text] [Related]
29. Celastrol antagonizes high glucose-evoked podocyte injury, inflammation and insulin resistance by restoring the HO-1-mediated autophagy pathway.
Zhan X; Yan C; Chen Y; Wei X; Xiao J; Deng L; Yang Y; Qiu P; Chen Q
Mol Immunol; 2018 Dec; 104():61-68. PubMed ID: 30439604
[TBL] [Abstract][Full Text] [Related]
30. Repression of miR-217 protects against high glucose-induced podocyte injury and insulin resistance by restoring PTEN-mediated autophagy pathway.
Sun J; Li ZP; Zhang RQ; Zhang HM
Biochem Biophys Res Commun; 2017 Jan; 483(1):318-324. PubMed ID: 28017719
[TBL] [Abstract][Full Text] [Related]
31. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
[TBL] [Abstract][Full Text] [Related]
32. Insulin signaling to the glomerular podocyte is critical for normal kidney function.
Welsh GI; Hale LJ; Eremina V; Jeansson M; Maezawa Y; Lennon R; Pons DA; Owen RJ; Satchell SC; Miles MJ; Caunt CJ; McArdle CA; Pavenstädt H; Tavaré JM; Herzenberg AM; Kahn CR; Mathieson PW; Quaggin SE; Saleem MA; Coward RJM
Cell Metab; 2010 Oct; 12(4):329-340. PubMed ID: 20889126
[TBL] [Abstract][Full Text] [Related]
33. Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB.
Zhao X; Chen Y; Tan X; Zhang L; Zhang H; Li Z; Liu S; Li R; Lin T; Liao R; Zhang Q; Dong W; Shi W; Liang X
J Pathol; 2018 Jun; 245(2):235-248. PubMed ID: 29570219
[TBL] [Abstract][Full Text] [Related]
34. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
[TBL] [Abstract][Full Text] [Related]
35. Metformin reduces TRPC6 expression through AMPK activation and modulates cytoskeleton dynamics in podocytes under diabetic conditions.
Szrejder M; Rachubik P; Rogacka D; Audzeyenka I; Rychłowski M; Kreft E; Angielski S; Piwkowska A
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165610. PubMed ID: 31778750
[TBL] [Abstract][Full Text] [Related]
36. Metformin overcomes high glucose-induced insulin resistance of podocytes by pleiotropic effects on SIRT1 and AMPK.
Rogacka D; Audzeyenka I; Rychłowski M; Rachubik P; Szrejder M; Angielski S; Piwkowska A
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):115-125. PubMed ID: 29032153
[TBL] [Abstract][Full Text] [Related]
37. Rosiglitazone enhances glucose uptake in glomerular podocytes using the glucose transporter GLUT1.
Lennon R; Welsh GI; Singh A; Satchell SC; Coward RJ; Tavaré JM; Mathieson PW; Saleem MA
Diabetologia; 2009 Sep; 52(9):1944-52. PubMed ID: 19533082
[TBL] [Abstract][Full Text] [Related]
38. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H
Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
[TBL] [Abstract][Full Text] [Related]
39. Renal protective effects of toll-like receptor 4 signaling blockade in type 2 diabetic mice.
Cha JJ; Hyun YY; Lee MH; Kim JE; Nam DH; Song HK; Kang YS; Lee JE; Kim HW; Han JY; Cha DR
Endocrinology; 2013 Jun; 154(6):2144-55. PubMed ID: 23568555
[TBL] [Abstract][Full Text] [Related]
40. Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2α-ATF-CHOP pathway in diabetic mice.
Kang MK; Park SH; Kim YH; Lee EJ; Antika LD; Kim DY; Choi YJ; Kang YH
Acta Pharmacol Sin; 2017 Aug; 38(8):1129-1140. PubMed ID: 28502979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
